| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2015 ( Subtotal = $997,966 ) |
| | 2015 | 2015 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R44AI094919 | GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine | 000 | 5 | NIH | 4/17/2015 | $997,966 |
|
| Issue Date FY: 2014 ( Subtotal = $997,804 ) |
| | 2014 | 2014 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R44AI094919 | GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine | 000 | 4 | NIH | 5/1/2014 | $997,804 |
|
| Issue Date FY: 2013 ( Subtotal = $996,995 ) |
| | 2013 | 2013 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R44AI094919 | GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine | 001 | 3 | NIH | 5/3/2013 | $996,995 |
| | 2013 | 2012 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R44AI094919 | GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine | 000 | 2 | NIH | 4/30/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $289,356 ) |
| | 2012 | 2012 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R44AI094919 | GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine | 000 | 2 | NIH | 4/13/2012 | $289,356 |
|
| Issue Date FY: 2011 ( Subtotal = $585,686 ) |
| | 2011 | 2011 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R44AI094919 | GelVac Stable, Dry-Powder Nasal Recombinant VLP-Based Bivalent Norovirus Vaccine | 000 | 1 | NIH | 4/29/2011 | $289,355 |
| | 2011 | 2011 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R43AI081394 | DEVELOPMENT OF A SYNTHETIC TYPHOID FEVER VACCINE AS A SUBSTITUTION OF VI VACCINE | 000 | 2 | NIH | 6/30/2011 | $296,331 |
|
| Issue Date FY: 2010 ( Subtotal = $299,614 ) |
| | 2010 | 2010 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R43AI081394 | DEVELOPMENT OF A SYNTHETIC TYPHOID FEVER VACCINE AS A SUBSTITUTION OF VI VACCINE | 000 | 1 | NIH | 6/25/2010 | $299,614 |
| | 2010 | 2010 | NANOTHERAPEUTICS INC | 12085 RESEARCH DRIVE | ALACHUA | FL | 32615 | ALACHUA | USA | R43AI081394 | DEVELOPMENT OF A SYNTHETIC TYPHOID FEVER VACCINE AS A SUBSTITUTION OF VI VACCINE | 001 | 1 | NIH | 8/6/2010 | $0 |
|
|
